Australia Hits Pfizer With Antitrust Suit Over Lipitor

By Dan Prochilo (February 13, 2014, 1:06 PM EST) -- Australia's competition regulator has sued the domestic unit of Pfizer Inc. over its marketing of the cholesterol-lowering drug Lipitor to pharmacies as the patent protection for the drug was about to expire, alleging the manufacturer abused its market power, the country's antitrust watchdog announced Thursday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!